185 related articles for article (PubMed ID: 19863576)
1. Novel sequence variation of AIRE and detection of interferon-omega antibodies in early infancy.
Tóth B; Wolff AS; Halász Z; Tar A; Szüts P; Ilyés I; Erdos M; Szegedi G; Husebye ES; Zeher M; Maródi L
Clin Endocrinol (Oxf); 2010 May; 72(5):641-7. PubMed ID: 19863576
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.
Wolff AS; Erichsen MM; Meager A; Magitta NF; Myhre AG; Bollerslev J; Fougner KJ; Lima K; Knappskog PM; Husebye ES
J Clin Endocrinol Metab; 2007 Feb; 92(2):595-603. PubMed ID: 17118990
[TBL] [Abstract][Full Text] [Related]
3. Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: using a new immunoprecipitation assay.
Larosa MDP; Mackenzie R; Burne P; Garelli S; Barollo S; Masiero S; Rubin B; Chen S; Furmaniak J; Betterle C; Smith BR
Clin Chem Lab Med; 2017 Jun; 55(7):1003-1012. PubMed ID: 28099118
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.
Meloni A; Furcas M; Cetani F; Marcocci C; Falorni A; Perniola R; Pura M; Bøe Wolff AS; Husebye ES; Lilic D; Ryan KR; Gennery AR; Cant AJ; Abinun M; Spickett GP; Arkwright PD; Denning D; Costigan C; Dominguez M; McConnell V; Willcox N; Meager A
J Clin Endocrinol Metab; 2008 Nov; 93(11):4389-97. PubMed ID: 18728167
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I.
Oftedal BE; Wolff AS; Bratland E; Kämpe O; Perheentupa J; Myhre AG; Meager A; Purushothaman R; Ten S; Husebye ES
Clin Immunol; 2008 Oct; 129(1):163-9. PubMed ID: 18708298
[TBL] [Abstract][Full Text] [Related]
6. AIRE gene mutations and autoantibodies to interferon omega in patients with chronic hypoparathyroidism without APECED.
Cervato S; Morlin L; Albergoni MP; Masiero S; Greggio N; Meossi C; Chen S; del Pilar Larosa M; Furmaniak J; Rees Smith B; Alimohammadi M; Kämpe O; Valenzise M; Betterle C
Clin Endocrinol (Oxf); 2010 Nov; 73(5):630-6. PubMed ID: 20718774
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the autoimmune regulator gene in patients with autoimmune non-APECED polyendocrinopathies.
Palma A; Gianchecchi E; Palombi M; Luciano R; Di Carlo P; Crinò A; Cappa M; Fierabracci A
Genomics; 2013 Sep; 102(3):163-8. PubMed ID: 23643663
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I.
Husebye ES; Perheentupa J; Rautemaa R; Kämpe O
J Intern Med; 2009 May; 265(5):514-29. PubMed ID: 19382991
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives.
Cervato S; Mariniello B; Lazzarotto F; Morlin L; Zanchetta R; Radetti G; De Luca F; Valenzise M; Giordano R; Rizzo D; Giordano C; Betterle C
Clin Endocrinol (Oxf); 2009 Mar; 70(3):421-8. PubMed ID: 18616706
[TBL] [Abstract][Full Text] [Related]
10. Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model.
Ahlgren KM; Moretti S; Lundgren BA; Karlsson I; Ahlin E; Norling A; Hallgren A; Perheentupa J; Gustafsson J; Rorsman F; Crewther PE; Rönnelid J; Bensing S; Scott HS; Kämpe O; Romani L; Lobell A
Eur J Immunol; 2011 Jan; 41(1):235-45. PubMed ID: 21182094
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1.
Vogel A; Liermann H; Harms A; Strassburg CP; Manns MP; Obermayer-Straub P
Hepatology; 2001 May; 33(5):1047-52. PubMed ID: 11343230
[TBL] [Abstract][Full Text] [Related]
12. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
13. The role of heterozygous mutations of the autoimmune regulator gene (AIRE) in non-APECED autoimmunity: a comment on recent findings.
Fierabracci A
Clin Endocrinol (Oxf); 2011 Apr; 74(4):532-3. PubMed ID: 21070315
[No Abstract] [Full Text] [Related]
14. Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients.
Meloni A; Willcox N; Meager A; Atzeni M; Wolff AS; Husebye ES; Furcas M; Rosatelli MC; Cao A; Congia M
J Clin Endocrinol Metab; 2012 Apr; 97(4):1114-24. PubMed ID: 22344197
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I.
Wolff AS; Oftedal BE; Kisand K; Ersvaer E; Lima K; Husebye ES
Scand J Immunol; 2010 Jun; 71(6):459-67. PubMed ID: 20500699
[TBL] [Abstract][Full Text] [Related]
16. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.
Collins SM; Dominguez M; Ilmarinen T; Costigan C; Irvine AD
Br J Dermatol; 2006 Jun; 154(6):1088-93. PubMed ID: 16704638
[TBL] [Abstract][Full Text] [Related]
17. The heterogeneity of autoimmune polyendocrine syndrome type 1: Clinical features, new mutations and cytokine autoantibodies in a Brazilian cohort from tertiary care centers.
Weiler FG; Peterson P; Costa-Carvalho BT; de Barros Dorna M; Correia-Deur JE; Sader SL; Espíndola-Antunes D; Guerra-Junior G; Dias-da-Silva MR; Lazaretti-Castro M
Clin Immunol; 2018 Dec; 197():231-238. PubMed ID: 30287219
[TBL] [Abstract][Full Text] [Related]
18. Novel and recurrent mutations in the AIRE gene of autoimmune polyendocrinopathy syndrome type 1 (APS1) patients.
Faiyaz-Ul-Haque M; Bin-Abbas B; Al-Abdullatif A; Abdullah Abalkhail H; Toulimat M; Al-Gazlan S; Almutawa AM; Al-Sagheir A; Peltekova I; Al-Dayel F; Zaidi SH
Clin Genet; 2009 Nov; 76(5):431-40. PubMed ID: 19758376
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.
Sarkadi AK; Taskó S; Csorba G; Tóth B; Erdős M; Maródi L
J Clin Immunol; 2014 Feb; 34(2):181-93. PubMed ID: 24493573
[TBL] [Abstract][Full Text] [Related]
20. Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED.
Cihakova D; Trebusak K; Heino M; Fadeyev V; Tiulpakov A; Battelino T; Tar A; Halász Z; Blümel P; Tawfik S; Krohn K; Lebl J; Peterson P
Hum Mutat; 2001 Sep; 18(3):225-32. PubMed ID: 11524733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
